Dabrafenib Impurity Reference Standard

  • Favorite
Guangzhou Dreampharm Biotechnology Co.,Ltd

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

8/10

Product Information

  • Indication:Not for clinical treatment; intended only for analytical testing, drug development, and quality control.
  • Specification:mg
  • Dosage Form:Others
  • Route of Administration:Oral
  • Shelf Life:18 months
  • Storage:Sealed
  • Place of Origin:China
  • Qualification:Chinese GMP

Description

Dabrafenib Impurity Reference Standard

This product is a high-purity impurity reference standard related to Dabrafenib, intended strictly for pharmaceutical research, analytical testing, impurity profiling, method development, validation, and quality control. It is not for clinical, therapeutic, or human use.

Typical Impurity Types (examples include but are not limited to):

  • Dabrafenib EP Impurity A

  • Dabrafenib EP Impurity B

  • Dabrafenib EP Impurity C

  • Dabrafenib USP Related Compounds

  • Other structurally related impurities of Dabrafenib

Key Features:

  • High-purity impurity reference standard (typically ≥95–98% by HPLC)

  • Supplied as solid powder in sealed, light-protective glass vials

  • Suitable for impurity profiling using HPLC, LC-MS, and related analytical techniques

  • Certificate of Analysis (COA) and characterization data available

Intended Use:

  • Identification and quantification of Dabrafenib-related impurities

  • Analytical method development and validation

  • Stability studies and regulatory submission support

Storage:
Store at 2–8 °C, protected from light and moisture. Reseal immediately after use.


You Might Also Like
Change a group
Inquiry Cart(0)